• Dermavant raises $200m to support tapinarof launch pharmaceutical-technology
    June 10, 2021
    Dermavant Sciences has signed a $160m revenue interest purchase and sale agreement for tapinarof with Marathon Asset Management, NovaQuest Capital Management and a third unnamed institutional investor in the US.
  • NovaQuest Private Equity Acquires CoreRx contractpharma
    January 20, 2021
    ​NovaQuest Private Equity has acquired CoreRx, a global contract development and manufacturing organization (CDMO).
PharmaSources Customer Service